Literature DB >> 10805102

Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.

T J Cummings1, J M Provenzale, S B Hunter, A H Friedman, G K Klintworth, S H Bigner, R E McLendon.   

Abstract

Gliomas of the optic nerve, although typically of pilocytic (WHO grade I) histology, can present within the spectrum of astrocytic neoplasia including glioblastoma (WHO grade IV). In certain cases, histologic features alone make the distinction between pilocytic and diffuse astrocytomas difficult. We reviewed 22 cases of optic nerve gliomas, 19 of which were pilocytic astrocytomas (PA), and 3 of which were diffuse, non-pilocytic astrocytomas. The cases were evaluated for their clinical course, radiographic appearance, histologic grade, and proliferation indices as detected by MIB-1 (Ki-67) and p53 antibodies. Of the 19 PA, 14 showed no tumor growth by magnetic resonance imaging, and had Ki-67 and p53 labeling indices (LI) of < 1%. The other 5 PA exhibited aggressive behavior manifest by marked diffuse infiltrative tumor growth causing death in 2 patients, 1 of whom was diagnosed with neurofibromatosis type 1 (immunoperoxidase and radiographs not available), and marked local growth with an average time to growth of 39.3 months, a Ki-67 LI of 2-3%, and a p53 LI of < 1% in three others. Three of the five aggressive PA histologically demonstrated a finely reticulated pattern, a pattern that appears as an exaggeration or expansion of the normal neuroglia of the optic nerve, and may simulate a diffuse low-grade astrocytoma. Two demonstrated the coarsely reticulated pattern, with the biphasic and microcystic pattern typical of PA. Three diffuse astrocytomas (2 anaplastic astrocytomas and 1 glioblastoma) originated clinically and radiographically from the optic nerve, and revealed a Ki-67 LI of 2-12%, a p53 LI of 2-8%, and an average time to growth of 8 months. We conclude that the majority of PA of the optic nerve are non-aggressive, stabilize radiographically, and have Ki-67 and p53 LI < 1%. However, a subpopulation of PA has a propensity for aggressive behavior, and are identified by a Ki-67 LI of 2-3% and a p53 LI of < 1%. Diffuse astrocytomas have both Ki-67 and p53 LI > 2%. Thus, in cases of aggressive optic nerve tumors in which the histologic review of biopsy material cannot confidently confirm the diagnosis of pilocytic or diffuse fibrillary glioma, a p53 LI of > 1% appears to favor the diagnosis of diffuse astrocytoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805102     DOI: 10.1007/s004010051161

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

Review 1.  Gamma Knife treatment of low-grade gliomas in children.

Authors:  Murat Şakir Ekşi; Baran Yılmaz; Akın Akakın; Zafer Orkun Toktaş; Ahmet Cemil Kaur; Mustafa Kemal Demir; Türker Kılıç
Journal:  Childs Nerv Syst       Date:  2015-07-15       Impact factor: 1.475

2.  An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis).

Authors:  J Douglas Cameron; Fausto J Rodriguez; Elisabeth Rushing; Iren Horkayne-Szakaly; Charles Eberhart
Journal:  Trans Am Ophthalmol Soc       Date:  2014

3.  Cavernous malformation of the optic pathway mimicking optic glioma: a case report.

Authors:  Yui Mano; Toshihiro Kumabe; Ryuta Saito; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2014-07-03       Impact factor: 1.475

4.  Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.

Authors:  Bum-Joo Cho; Hyeong Gon Yu
Journal:  J Neurooncol       Date:  2014-08-15       Impact factor: 4.130

Review 5.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

6.  Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.

Authors:  Fu Zhao; Jing Zhang; Peng Li; Qiangyi Zhou; Shun Zhang; Chi Zhao; Bo Wang; Zhijun Yang; Chunde Li; Pinan Liu
Journal:  J Neurooncol       Date:  2018-04-23       Impact factor: 4.130

Review 7.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

8.  Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.

Authors:  Fausto J Rodriguez; Arie Perry; David H Gutmann; Brian Patrick O'Neill; Jeffrey Leonard; Sandra Bryant; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2008-03       Impact factor: 3.685

9.  Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.

Authors:  Roy E Strowd; Fausto J Rodriguez; Roger E McLendon; James J Vredenburgh; Aaron B Chance; George Jallo; Alessandro Olivi; Edward S Ahn; Jaishri O Blakeley
Journal:  Am J Med Genet A       Date:  2016-03-14       Impact factor: 2.802

Review 10.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.